SARs has long been used to design chemicals with commercially desirable properties with expected pharmacologic and therapeutic activities. Moreover, computer-based modeling methods, as well as AI-driven approaches relating chemical structure to qualitative biological activity and quantitative biological potency have been widely applied in diverse problem settings. CD ComputaBio provides intelligent services of structure activity relationship analysis and development for our clients in different stage of drug discovery, especially for screening large numbers of chemicals and decision making during chemical optimization.
